TITLE

Manitoba researchers set sights on cancer vaccine

AUTHOR(S)
Square, David
PUB. DATE
October 1998
SOURCE
CMAJ: Canadian Medical Association Journal;10/20/98, Vol. 159 Issue 8, p910
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on research that is trying to isolate genetic differences between invasive breast cancer and metastasis. Researchers Leigh Murphy and Peter Watson of the University of Manitoba; The hopes that a treatment to retard the growth of malignant cells in humans will be found; Their 2-year grant from the Pasteur Merieux Connaught Cancer Vaccine Network.
ACCESSION #
1214839

 

Related Articles

  • Blood ties & breast cancer. Griffin, Katherine // Good Housekeeping;Oct2001, Vol. 233 Issue 4, p158 

    Focuses on developments in breast cancer. Genetic screening of women at risk for the disease; Preventive strategies; Background on the condition of breast cancer survivors.

  • Predisposición genética para el cáncer de mama: genes BRCA1 y BRCA2. Narod, Steven A; Rodríguez, Adriana A // Salud Pública de México;sep/oct2011, Vol. 53 Issue 5, p420 

    The discovery of genes BRCA1 and BRCA2 has led to the introduction of genetic tests more complex every time for the evaluation of the hereditary cancer risk, among others. In the present paper we explore the criteria to decide when to run the testing for the genes, as well as the implications...

  • Most parents who get tested for breast cancer genes share results with their children.  // Biomedical Market Newsletter;1/14/2012, Vol. 21, p1 

    The article presents information a research conducted in order to evaluate the risk faced by children whose parents get tested for breast cancer genes. It describes the involvement of two common breast cancer-related genes (BRCA1 and BRCA2) in genetic testing for mutations. The study revealed...

  • Guidelines for Genetic Risk Assessment of Hereditary Breast and Ovarian Cancer: Early Disagreements and Low Utilization. Levy, Douglas E.; Garber, Judy E.; Shields, Alexandra E. // JGIM: Journal of General Internal Medicine;Jul2009, Vol. 24 Issue 7, p822 

    BRCA1/2 testing is one of the most well-established genetic tests to predict cancer risk. Guidelines are available to help clinicians determine who will benefit most from testing. To identify women at high risk of hereditary breast and ovarian cancer and estimate their awareness of and...

  • PATENTING RACE: THE PROBLEMS OF ETHNIC GENETIC TESTING PATENTS. Price, II, W. Nicholson // Columbia Science & Technology Law Review;2008, Vol. 9, p119 

    Genetic tests which target specific ethnicities are fraught with problems, and will become commonplace unless action is taken to stop them. The first has already been patented in Europe by the U.S. company Myriad Genetics, despite vigorous opposition. Myriad's patent covers testing for a...

  • GINA: What PAs need to know to protect patients and their families. Goldgar, Constance // JAAPA: Journal of the American Academy of Physician Assistants (;Jul2010, Vol. 23 Issue 7, p56 

    The article offers information about Genetic Information Nondiscrimination Act (GINA) in the U.S. A case of a 39-year-old woman with an invasive breast cancer was presented to illustrate the concept of a diagnosed genetic condition in a patient and a family member's increased risk of developing...

  • Prognosis progress. HARRIS, STEPHEN // Engineer (00137758);Oct2014, Vol. 296 Issue 7856, p13 

    The article looks at a technology developed by graduates of Cambridge University in England that can automate breast cancer diagnosis and help prevent unnecessary treatment for women. Topics mentioned include the possible use of the genetic diagnostic system to determine the spread of the tumor,...

  • Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer. Pruthi, Sandhya; Gostout, Bobbie S.; Lindor, Noralane M. // Mayo Clinic Proceedings;Dec2010, Vol. 85 Issue 12, p1111 

    Women with a germline BRCA1 or BRCA2 mutation or a hereditary predisposition for breast and ovarian cancer have substantial risk of breast or ovarian cancer relative to the general US population. Health care professionals can be instrumental in identifying women at increased risk through...

  • Managing BRCA Mutation Carriers in China. Kalogerakos, Kyriakos // World Journal of Surgery;Feb2011, Vol. 35 Issue 2, p458 

    The article focuses on the report by A. Kwong and colleagues concerning the hereditary breast-ovarian cancer (HBOC) syndrome in China published in the July 2010 issue of "World Journal of Surgery." The report used retrospective analysis and found out that most Chinese breast cancer (BRCA)...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics